erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Meningitis, Haemophilus D008583 3 associated lipids
Uterine Cervical Incompetence D002581 3 associated lipids
Kidney Diseases, Cystic D052177 3 associated lipids
Impetigo D007169 3 associated lipids
Bartonella Infections D001474 3 associated lipids
Fractures, Open D005597 3 associated lipids
Pityriasis Rosea D017515 3 associated lipids
Drug-Related Side Effects and Adverse Reactions D064420 3 associated lipids
Communicable Diseases, Emerging D021821 3 associated lipids
Heart Block D006327 3 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
CRONK GA and NAUMANN DE Ilotycin (erythromycin) for fusospirochetal infections of the oro-pharynx; a progress report. 1953 J Lancet pmid:13221896
VELEZ MORAN C [Experience with erythromycin in the Hospital de Aislamiento de Guayaquil]. 1953 Rev Ecuat Hig Med Trop pmid:13237604
AUSTRIAN R and ROSENBLUM R The relative efficacy of erythromycin (ilotycin) and of penicillin in the treatment of pneumococcal lobar pneumonia. 1953 Am. J. Med. Sci. pmid:13104398
LIVINGOOD CS et al. Erythromycin in local treatment of cutaneous bacterial infections. 1953 J Am Med Assoc pmid:13108585
RUIZ SANCHEZ F et al. [Clinical experiences with carbomycin and erythromycin]. 1953 Medicina (Mex) pmid:13110596
SCHONBERG IL The treatment of pyogenic skin infections with ilotycin ointment (erythromycin). 1953 Ohio Med pmid:13111755
MARTIN WJ et al. The present status of erythromycin. 1953 Proc Staff Meet Mayo Clin pmid:13112261
PERLMAN D Colorimetric method for determination of aureomycin, carbomycin, erythromycin, and terramycin in aqueous solution. 1953 Science pmid:13113207
TALLEY RW Clinical evaluation of erythromycin. 1953 South. Med. J. pmid:13113414
HEDENIUS P and TUNEVALL HG [Erythromycin, its antibacterial effect in vitro, its absorption and excretion, with a preliminary report on a series of cases with erythromycin therapy]. 1953 Sven Lakartidn pmid:13113605
GRIGSBY ME et al. Some laboratory and clinical experiences with erythromycin. 1953 Antibiot Chemother (Northfield) pmid:24542704
RUIZ SANCHEZ F et al. [Erythromycin in the treatment of diarrheas due to Micrococcus pyogenes]. 1953 Medicina (Mex) pmid:13098728
HASBROUCK RB and GARVEN FC The chemistry of erythromycin. II. Acid degradation products. 1953 Antibiot Chemother (Northfield) pmid:24542706
DIPHTHERIA carriers rapidly cleared. 1953 Whats New pmid:24542774
PYODERMA responds to erythromycin ointment. 1953 Whats New pmid:24542848
DORE R [Basal metabolism; significance and interpretation]. 1953 Union Med Can pmid:13122881
ANDERSON EA Cure of resistant meningococcemia with erythromycin. 1953 Antibiot Chemother (Northfield) pmid:24542853
DEARING WH Micrococcic (staphylococcic) enteritis as a complication of antibiotic therapy; its response to erythromycin. 1953 Proc Staff Meet Mayo Clin pmid:13037897
NEW antibiotic. 1953 South. Med. J. pmid:13038549
FREEMAN LC and SCOTT RB Erythromycin in treatment of pyoderma in children. 1953 J. Pediatr. pmid:13053367
NESERKE EI Clinical report on the new antibiotic, erythromycin. 1953 J. Am. Vet. Med. Assoc. pmid:13061363
GABLE GR et al. Treatment of gonorrhea with erythromycin. 1953 Am J Syph Gonorrhea Vener Dis pmid:13065617
HERRELL WE et al. Erythromycin for infections due to Micrococcus pyogenes. 1953 J Am Med Assoc pmid:13069224
BAZAN C et al. [Treatment of whooping cough with erythromycin]. 1953 Rev Chil Pediatr pmid:13134787
BRICAIRE H and DE FOSSEY B [Two new antibiotics: erythromycin and soframycin]. 1953 Rev Prat pmid:13135190
VANNUCCHI V [Ilotycin sulfa: association of ilotycin with a trisulfonamide]. 1953 Riv Crit Clin Med pmid:14358369
HAIGHT TH and FINLAND M The antibacterial action of erythromycin. 1952 Proc. Soc. Exp. Biol. Med. pmid:13047351
VANNUCCHI V [Clinical study of a new antibiotic; erythromycin]. 1952 Riv Crit Clin Med pmid:13056483
ERYTHROMYCIN. 1952 Br Med J pmid:12987755
ANDERSON RC et al. The toxicity and distribution of ilotycin. 1952 J Am Pharm Assoc Am Pharm Assoc pmid:12999613
ERYTHROMYCIN, new and promising antibiotic. 1952 N. Engl. J. Med. pmid:14947939
HAIGHT TH and FINLAND M Laboratory and clinical studies on erythromycin. 1952 N. Engl. J. Med. pmid:14947931
ERYTHROMYCIN: another antibiotic. 1952 Lancet pmid:14939901
Sakushima A et al. Guaiacylglycerol-7'-O-methyl 8'-vanillic acid ether and related compounds from Boreava orientalis. Phytochem Anal pmid:12597255
Bottega A et al. Evaluation of constitutive and inducible resistance to clindamycin in clinical samples of Staphylococcus aureus from a tertiary hospital. Rev. Soc. Bras. Med. Trop. pmid:25467260
pmid:17760348
Zhou W et al. Erythromycin-resistant genes in group A β-haemolytic Streptococci in Chengdu, Southwestern China. Indian J Med Microbiol pmid:25008823
Abraham T and Sistla S Trends in antimicrobial resistance patterns of Group A streptococci, molecular basis and implications. Indian J Med Microbiol pmid:30084408
pmid:
Pranteda G et al. Pitted keratolysis, erythromycin, and hyperhidrosis. Dermatol Ther pmid:24703267
Wang X et al. Phenotypic and molecular characterization of Streptococcus agalactiae colonized in Chinese pregnant women: predominance of ST19/III and ST17/III. Res. Microbiol. pmid:29378338
Yayan J and Rasche K Growing Antibiotic Resistance in Fatal Cases of Staphylococcal Pneumonia in the Elderly. Adv. Exp. Med. Biol. pmid:26747068
Alvarez-Sánchez M et al. [Bacterial resistance in acne? A meta-analysis of the controversy]. Cir Cir pmid:26738649
Mondragón-Navarro M et al. Potential association between erythromycin and cholestatic hepatitis. Med Intensiva pmid:26707838
Gencoglan G et al. Therapeutic hotline: Treatment of prurigo nodularis and lichen simplex chronicus with gabapentin. Dermatol Ther pmid:20415827
Jahansepas A et al. Occurrence of Enterococcus faecalis and Enterococcus faecium in Various Clinical Infections: Detection of Their Drug Resistance and Virulence Determinants. Microb. Drug Resist. pmid:28525287
Silva V et al. Genetic Characterization of vanA-Enterococcus faecium Isolates from Wild Red-Legged Partridges in Portugal. Microb. Drug Resist. pmid:28504889
McCutcheon K and Manga P An antibiotic recipe for an arrhythmic disaster. Cardiovasc J Afr pmid:26592910
Commerford PJ From the Editor's Desk. Cardiovasc J Afr pmid:26592903
Fallahpour N et al. Overproduction of Erythromycin by Ultraviolet Mutagenesis and Expression of ermE Gene in Saccharopolyspora erythraea. Assay Drug Dev Technol pmid:29120674